India Veterinary Medicine Market Summary
The India veterinary medicine market size was estimated at USD 1.73 billion in 2024 and is projected to reach USD 4.17 billion by 2033, growing at a CAGR of 10.23% from 2025 to 2033. The market is experiencing growth due to rising awareness about the importance of animal healthcare, a growing number of animal disease outbreaks, and increasing demand for animal-derived protein. Additionally, new product launches, advancements in veterinary medicine, and strong regulatory support contribute to this growth. Government initiatives in India, such as the National Programme for Dairy Development, the Rashtriya Gokul Mission, and the Animal Husbandry Infrastructure Development Fund, are also key in driving market expansion.Moreover, in 2024, India ramped up efforts to increase milk production through strategic public-private partnerships, which have notably influenced the country’s veterinary medicine market. In collaboration with private stakeholders, the government introduced several initiatives to strengthen dairy infrastructure and boost productivity. For example, as reported by EGNIOL in February 2024, one key initiative is the Animal Husbandry Infrastructure Development Fund (AHIDF)-a ₹15,000 crore (USD 1.71 billion) fund designed to attract private sector investment in areas such as dairy plants, meat processing units, and animal feed facilities. This program aims to support Farmer Producer Organizations (FPOs), Micro, Small, and Medium Enterprises (MSMEs), and individual entrepreneurs engaged in the animal husbandry sector.
Similarly, the Indian government has been actively promoting the development of the veterinary medicine market through various initiatives. One of these initiatives includes establishing the National Animal Disease Control Program (NADCP), which aims to control and eradicate major animal diseases in the country. Additionally, the government has launched several schemes to encourage the use of modern veterinary practices and technologies, driving market growth. For instance, in June 2023, the Indian government launched the Nandi portal, a tool developed by the Central Drugs Standard Control Organization and in collaboration with the Department of Animal Husbandry and Dairying (DAHD) to streamline the regulatory approval process for veterinary products, aiming to enhance transparency and efficiency in assessing and examining proposals for veterinary drugs and vaccines.
India’s vast livestock population of over 536 million, the largest globally, combined with the heavy dependence of nearly 70% of rural households on animals for livelihood, food security, and income, creates a strong foundation for sustained demand in the veterinary medicine market. Government initiatives such as the National Animal Disease Control Programme (NADCP) significantly amplify this demand. As reported by the Ministry of Fisheries, Animal Husbandry & Dairying in April 2025, massive vaccine deployment-114.56 crore FMD doses and 4.57 crore Brucellosis doses reflects the scale of national efforts to curb endemic diseases. The NADCP’s dual goals of controlling Foot and Mouth Disease (FMD) by 2025 and eradicating it 2030 through regular immunization directly stimulate demand for vaccines, diagnostics, and therapeutic veterinary products. These large-scale disease eradication programs increase public and private investments, improve supply chain infrastructure, and create long-term opportunities for pharmaceutical companies and service providers. Consequently, the emphasis on preventive healthcare and mass vaccination is a key driver accelerating growth in India's veterinary medicine market.
India Veterinary Medicine Market Report Segmentation
This report forecasts revenue growth provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the India veterinary medicine market report based on product, animal type, route of administration, and distribution channel:Animal Type Outlook (Revenue, USD Million, 2021 - 2033)
- Production Animals
- Poultry
- Pigs
- Cattle
- Sheep & Goats
- Others
- Companion Animals
- Dogs
- Cats
- Horses
- Others
Product Outlook (Revenue, USD Million, 2021 - 2033)
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
- Medicated Feed Additives
Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
- Oral
- Injectable
- Topical
- Others
Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Veterinary Hospitals & Clinics
- E-commerce
- Offline Retail Stores
- Others
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. India Veterinary Medicine Market Variable Trends & Scope
Chapter 4. India Veterinary Medicine Market: Animal Type Estimates & Trend Analysis
Chapter 5. India Veterinary Medicine Market: Product Estimates & Trend Analysis
Chapter 6. India Veterinary Medicine Market: By Route of Administration Estimates & Trend Analysis
Chapter 7. India Veterinary Medicine Market: By Distribution Channel Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Boehringer Ingelheim International GmbH
- Zoetis
- IDEXX Laboratories, Inc.
- Merck & Co., Inc.
- Elanco
- Hester Biosciences Limited
- Ceva Santé Animale
- Phibro Animal Health Corporation
- Virbac
- Dechra Pharmaceuticals Plc
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 150 |
Published | July 2025 |
Forecast Period | 2024 - 2033 |
Estimated Market Value ( USD | $ 1.73 Billion |
Forecasted Market Value ( USD | $ 4.17 Billion |
Compound Annual Growth Rate | 10.2% |
Regions Covered | India |
No. of Companies Mentioned | 10 |